Literature DB >> 10917774

No evidence of active infection with human herpesvirus 6 (HHV-6) or HHV-8 in chronic fatigue syndrome.

M Enbom, A Linde, B Evengård.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10917774      PMCID： PMC86845          DOI： 10.1128/JCM.38.6.2457-2457.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  8 in total

1.  HHV-6 reactivation in chronic fatigue syndrome.

Authors:  S F Josephs; B Henry; N Balachandran; D Strayer; D Peterson; A L Komaroff; D V Ablashi
Journal:  Lancet       Date:  1991-06-01       Impact factor: 79.321

2.  Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.

Authors:  T Sairenji; K Yamanishi; Y Tachibana; G Bertoni; T Kurata
Journal:  Intervirology       Date:  1995       Impact factor: 1.763

3.  Lymphotropic herpesviruses in allogeneic bone marrow transplantation.

Authors:  F Z Wang; H Dahl; A Linde; M Brytting; A Ehrnst; P Ljungman
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

4.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

5.  Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome.

Authors:  M Patnaik; A L Komaroff; E Conley; E A Ojo-Amaize; J B Peter
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

6.  Prevalence of human herpesvirus 6 variants A and B in patients with chronic fatigue syndrome.

Authors:  S Yalcin; H Kuratsune; K Yamaguchi; T Kitani; K Yamanishi
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

7.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome.

Authors:  D Di Luca; M Zorzenon; P Mirandola; R Colle; G A Botta; E Cassai
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948
  8 in total
  7 in total

Review 1.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Human herpesvirus 6 infection as a trigger of multiple sclerosis.

Authors:  Konstantine I Voumvourakis; Dimitrios K Kitsos; Sotirios Tsiodras; George Petrikkos; Eleftherios Stamboulis
Journal:  Mayo Clin Proc       Date:  2010-10-06       Impact factor: 7.616

3.  Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.

Authors:  Ulrike Gerdemann; Laura Keukens; Jacqueline M Keirnan; Usha L Katari; Chinh T Q Nguyen; Anne P de Pagter; Carlos A Ramos; Alana Kennedy-Nasser; Stephen M Gottschalk; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Ann M Leen
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

Review 4.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

5.  Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Sayed-Hamidreza Mozhgani; Farid Rajabi; Mohsen Qurbani; Yousef Erfani; Somayeh Yaslianifard; Azam Moosavi; Kiomars Pourrostami; Ali Baradaran Bagheri; Alireza Soleimani; Farida Behzadian; Mahshid Safavi; Farhad Rezaei
Journal:  Intervirology       Date:  2021-06-23       Impact factor: 1.763

Review 6.  A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?

Authors:  Navena Navaneetharaja; Verity Griffiths; Tom Wileman; Simon R Carding
Journal:  J Clin Med       Date:  2016-06-06       Impact factor: 4.241

7.  Serum levels of matrix metalloproteinase-2, -9, and vitamin D in patients with multiple sclerosis with or without herpesvirus-6 seropositivity.

Authors:  Razieh Amini; Sajad Karampoor; Hamid Zahednasab; Hossein Keyvani; Masoud Gheiasian; Farid Azizi Jalilian
Journal:  Braz J Infect Dis       Date:  2020-03-31       Impact factor: 3.257
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.